$20.34
0.391.98%
Last update: Nov 5, 10:16 AM

The average analyst price target for Amneal Pharmaceuticals is $17.60, 13.5% below the current price. Of 8 analysts, 8 rate it Buy. Targets range from $7 to $27. The latest change came on Nov 4, 2026, when JP Morgan raised its price target on Amneal Pharmaceuticals from $24 to $25 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months